ProfileGDS4095 / 208552_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 38% 32% 35% 37% 36% 37% 36% 36% 30% 33% 38% 36% 33% 35% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.6539338
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.4174732
GSM709765LY2 SRC1-siRNA untreated rep32.5606835
GSM709771LY2 SRC1-siRNA untreated rep12.6221637
GSM709772LY2 SRC1-siRNA untreated rep22.575936
GSM709775LY2 SRC1-siRNA untreated rep42.6432737
GSM709764LY2 control-siRNA tamoxifen treated rep22.6130236
GSM709766LY2 control-siRNA tamoxifen treated rep32.5963436
GSM709768LY2 control-siRNA tamoxifen treated rep12.360330
GSM709777LY2 control-siRNA tamoxifen treated rep42.4703533
GSM709770LY2 control-siRNA untreated rep32.6423338
GSM709773LY2 control-siRNA untreated rep12.5779636
GSM709774LY2 control-siRNA untreated rep22.4604833
GSM709776LY2 control-siRNA untreated rep42.5583235